| アブストラクト | BACKGROUND: While opioid analgesics are often necessary for the management of acute postoperative pain, appropriate prescribing practices are crucial to avoid harm. The aim was to investigate the changes in the proportion of people receiving initial opioid prescriptions after hospital discharge following colectomy, and describe trends and patterns in prescription characteristics. METHODS: This was a retrospective cohort study. Patients undergoing colectomy in England between 2010 and 2019 were included using electronic health record data from linked primary (Clinical Practice Research Datalink Aurum) and secondary (Hospital Episode Statistics) care. The proportion of patients having an initial opioid prescription issued in primary care within 90 days of hospital discharge was calculated. Prescription characteristics of opioid type and formulation were described. RESULTS: Of 95 155 individuals undergoing colectomy, 15 503 (16.3%) received opioid prescriptions. There was a downward trend in the proportion of patients with no prior opioid exposure (opioid naive) who had a postdischarge opioid prescription (P <0.001), from 11.4% in 2010 to 6.7% in 2019 (-41.3%, P <0.001), whereas the proportions remained stable for those prescribed opioids prior to surgery, from 57.5% in 2010 to 58.3% in 2019 (P = 0.637). Codeine represented 44.5% of all prescriptions and prescribing increased by 14.5% between 2010 and 2019. Prescriptions for morphine and oxycodone rose significantly by 76.6% and 31.0% respectively, while tramadol prescribing dropped by 48.0%. The most commonly prescribed opioid formulations were immediate release (83.9%), followed by modified release (5.8%) and transdermal (3.2%). There was a modest decrease in the prescribing of immediate-release formulations from 86.0% in 2010 to 82.0% in 2019 (P <0.001). CONCLUSION: Over the 10 years studied, there was a changing pattern of opioid prescribing following colectomy, with a decrease in the proportion of opioid-naive patients prescribed postdischarge opioids. |
|---|
| 組織名 | Division of Pharmacy Practice and Policy, School of Pharmacy, University of;Nottingham, Nottingham, UK.;Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University,;Jeddah, Saudi Arabia.;Nottingham Digestive Diseases Centre, Division of Translational Medical Sciences,;School of Medicine, University of Nottingham, Queen's Medical Centre, Nottingham,;UK.;National Institute for Health Research Nottingham Biomedical Research Centre,;Nottingham University Hospitals NHS Trust and University of Nottingham, Queen's;Medical Centre, Nottingham, UK.;Pain Centre Versus Arthritis, University of Nottingham, Nottingham, UK.;David Greenfield Metabolic Physiology Unit, MRC Versus Arthritis Centre for;Musculoskeletal Ageing Research, School of Life Sciences, University of;Nottingham, Queen's Medical Centre, Nottingham, UK.;Department of Surgery, Perelman School of Medicine, University of Pennsylvania,;Philadelphia, Pennsylvania, USA. |
|---|
